KLG Stock +78.58% In 3 Months Since We Picked KLG Stock +78.58% In 3 Months Since We Picked Unlock All Top Buy Picks

Range Low Price High Price Comment
30 days $1.24 $2.30 Friday, 26th Apr 2024 ATOS stock ended at $1.53. This is 0.658% more than the trading day before Thursday, 25th Apr 2024. During the day the stock fluctuated 5.63% from a day low at $1.51 to a day high of $1.60.
90 days $0.82 $2.30
52 weeks $0.600 $2.30

Historical Atossa Genetics Inc. prices

Date Open High Low Close Volume
Mar 07, 2016 $72.00 $73.80 $68.40 $68.40 4 406
Mar 04, 2016 $79.20 $79.20 $72.00 $73.80 1 783
Mar 03, 2016 $82.80 $88.20 $77.40 $79.20 2 855
Mar 02, 2016 $79.20 $88.20 $75.60 $82.80 5 968
Mar 01, 2016 $75.60 $75.60 $68.40 $72.00 1 600
Feb 29, 2016 $75.60 $81.00 $68.40 $75.60 2 121
Feb 26, 2016 $81.00 $81.00 $70.20 $75.60 2 196
Feb 25, 2016 $88.20 $88.20 $77.40 $79.20 1 321
Feb 24, 2016 $88.20 $88.20 $72.00 $86.40 2 970
Feb 23, 2016 $104.40 $108.00 $88.20 $88.20 4 133
Feb 22, 2016 $111.60 $115.20 $100.80 $108.00 5 467
Feb 19, 2016 $97.20 $106.20 $91.80 $102.60 6 337
Feb 18, 2016 $113.40 $113.40 $84.60 $88.20 11 194
Feb 17, 2016 $122.40 $127.80 $104.40 $118.80 22 519
Feb 16, 2016 $90.00 $99.00 $75.60 $99.00 14 154
Feb 12, 2016 $41.40 $64.80 $41.40 $55.80 4 386
Feb 11, 2016 $39.60 $43.20 $37.80 $39.60 805
Feb 10, 2016 $41.40 $43.20 $39.60 $39.60 738
Feb 09, 2016 $43.20 $43.20 $41.40 $41.40 498
Feb 08, 2016 $46.80 $48.60 $41.40 $43.20 927
Feb 05, 2016 $45.00 $46.80 $43.20 $46.80 971
Feb 04, 2016 $45.00 $46.80 $43.20 $45.00 537
Feb 03, 2016 $46.80 $48.60 $43.20 $46.80 1 132
Feb 02, 2016 $48.60 $50.40 $45.00 $46.80 1 082
Feb 01, 2016 $48.60 $50.40 $46.80 $50.40 1 171
Click to get the best stock tips daily for free!

About Atossa Genetics Inc.

Atossa Genetics Atossa Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery and development of medicines in the areas of oncology and infectious diseases. The company's lead program is Endoxifen, an active metabolite of tamoxifen, which is in Phase II clinical trials to treat and prevent breast cancer. It is also developing AT-H201, an inhalation therapy to improve lung function in severely ill and hospitalized COVID-19 patien... ATOS Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT